Banco Bilbao Vizcaya Argentaria’s Novo Nordisk NVO Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.46M	Sell	92,930 -1,166,479	-93%	-$50.1M	0.03%	309
2026 Q1	$45.1M	Buy	1,259,409 +913,823	+264%	+$43.3M	0.32%	52
2025 Q4	$17.6M	Sell	345,586 -11,935	-3%	-$610K	0.12%	133
2025 Q3	$19.5M	Buy	357,521 +257,306	+257%	+$15.1M	0.15%	122
2025 Q2	$6.92M	Sell	100,215 -11,808	-11%	-$803K	0.06%	224
2025 Q1	$7.77M	Buy	112,023 +12,553	+13%	+$1.04M	0.08%	210
2024 Q4	$8.55M	Buy	99,470 +95,236	+2,249%	+$10.3M	0.09%	194
2024 Q3	$501K	Buy	+4,234	New	+$565K	0.01%	619

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's NVO Position: Q2 2026 in Review

Banco Bilbao Vizcaya Argentaria reduced its Novo Nordisk (NVO) stake by 93% in Q2 2026, selling an estimated $50.1M and leaving 92,930 shares worth $4.46M. The position accounts for 0.03% of the portfolio, ranked #309.

Banco Bilbao Vizcaya Argentaria first reported a position in NVO in Q3 2024 and has held it in 8 quarters since. The position peaked at $45.1M in Q1 2026. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Banco Bilbao Vizcaya Argentaria held 92,930 shares of Novo Nordisk worth $4.46M as of Q2 2026.
Banco Bilbao Vizcaya Argentaria sold 1,166,479 Novo Nordisk shares in Q2 2026, an estimated $50.1M.
Novo Nordisk made up 0.03% of Banco Bilbao Vizcaya Argentaria's portfolio in Q2 2026, its #309 holding.
Banco Bilbao Vizcaya Argentaria first reported a position in Novo Nordisk in Q3 2024 and has held it in 8 quarters since.
Banco Bilbao Vizcaya Argentaria's Novo Nordisk position peaked at $45.1M in Q1 2026.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2026, filed 12 Aug 2026.